Effect of 3,4‐Methylenedioxymethamphetamine on 3,4‐Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens
J. Frank Nash, Herbert Y. Meltzer, Gary A. Gudelsky
Journal of Neurochemistry March 1, 1990 DOI: 10.1111/j.1471-4159.1990.tb02358.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Rats (nigrostriatal and mesolimbic brain regions) |
| Interventions | MDMA ketanserin |
| Dose | 20 mg/kg |
| Duration | 3 hours and 7 days after MDMA administration |
| Measures | DOPA accumulation, 5-HT concentration, 5-HIAA concentration |
| Topics | MDMA |
| Key findings | MDMA increased DOPA accumulation in the striatum more than in the nucleus accumbens, and reduced 5-HT and 5-HIAA in both regions at 3 hours but only in the striatum at 7 days. Ketanserin blocked MDMA-induced DOPA accumulation and the 7-day 5-HT depletion, suggesting MDMA acts via 5-HT2 receptors and that dopamine contributes to 5-HT depletion. |
Abstract
Abstract: The effect of the racemic mixture of 3,4‐methy‐lenedioxymethamphetamine (MDMA) on the synthesis of dopamine in the terminals of nigrostriatal and mesolimbic neurons was estimated by measuring the accumulation of 3,4‐dihydroxyphenylalanine (DOPA) in the striatum and nucleus accumbens 30 min following the administration of the l‐aromatic amino acid decarboxylase inhibitor, 3‐hydroxybenzylhydrazine. MDMA produced an increase in DOPA accumulation in the striatum which was greater in magnitude and longer in duration than that in the nucleus accumbens. Although the concentrations of serotonin (5‐HT) and 5‐hydroxyindoleacetic acid (5‐HIAA) in both the striatum and nucleus accumbens were reduced 3 h following an injection of MDMA (20 mg/kg), 5‐HT and 5‐HIAA concentrations were significantly reduced only in the striatum 7 days after the administration of MDMA. Pretreatment with a 5‐HT2 antagonist, ketanserin, significantly attenuated the reduction in 5‐HT concentration in the striatum 3 h following MDMA administration and completely blocked 5‐HT depletion at 7 days post administration. Moreover, ketanserin completely blocked MDMA‐induced DOPA accumulation in the striatum. The results obtained in these studies suggest that MDMA activates nigrostriatal dopaminergic pathways via 5‐HT2 receptors. In addition, these data are supportive of the hypothesis that dopamine plays a role in MDMA‐induced 5‐HT depletion.
Comparable studies
Other preclinical and animal studies on MDMA, most cited first.
Citations in the library
Cited by 24
- 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans Addiction May 1, 1994
- 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine European Journal of Pharmacology November 1, 1992
- Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. European Journal of Pharmacology November 3, 1994
- Blockade of Striatal 5‐Hydroxytryptmine2Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine Journal of Neurochemistry April 1, 1994
- The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine Biological Chemistry January 2, 2011
and 19 more in the library
Cites 10
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity Journal of Neuroscience August 1, 1988
- Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics 1987
- (±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates JAMA July 1, 1988
- Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Biochemical Pharmacology July 15, 1987
- Effects of certain hallucinogenic amphetamine analogs on the release of [3H]-serotonin from rat brain synaptosomes Journal of Medicinal Chemistry May 1, 1982
and 5 more in the library